Skip to main content

Valsartan Cases Stayed Until The Next Case Management Order

Valsartan Cases Stayed Until The Next Case Management Order

Valsartan Cases Stayed Until The Next Case Management Order

Introduction

U.S. District Judge Robert B. Kugler, presiding over all federal valsartan lawsuits, issued an order on February 25, to stay all pending deadlines entered in these cases before the valsartan multidistrict litigation (MDL) was established. The stay will remain effective until any further orders are issued at the end of an initial case management conference scheduled for March 27.

The stay request was filed by generic drug makers to suspend or vacate all deadlines established before the formation of the federal MDL. The product liability claims and class actions filed against the drug makers alleged that the generic versions of the hypertension medicine contained cancer-causing chemicals, including N-nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA). The complaints also involved claims that the patients were diagnosed with liver cancer, kidney cancer, bladder cancer, stomach cancer, and other digestive tract cancers due to the consumption of tainted medicines.

If the manufacturers are unsuccessful in reaching on a settlement agreement or resolution for the litigation, individual cases might be remanded back to the U.S. District Court for a future trial date.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to $7.4B Opioid Settlement

Categories: Opioids

Purdue Pharma and its owners, the Sackler family, have agreed to a $7.4 billion settlement to resolve thousands of lawsuits accusing the…

Paraquat Trials Scheduled for October 2025 & April 2026

Categories: Paraquat

A U.S. District Judge overseeing thousands of federal

UGA College of Pharmacy Gets $1M+ to Fight Opioid Crisis

Categories: Opioids

Faculty from the University of Georgia’s College of Pharmacy have been awarded a nearly $1.2 million grant from the Georgia Opioid Crisis…

Get 5 Free Medical Record Reviews – No Risk, No Contracts!      
Only 10 firms will be accepted!

Valid until February 28, 2025.